Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,091,596
  • Shares Outstanding, K 79,851
  • Annual Sales, $ 3,898 M
  • Annual Income, $ 887,870 K
  • EBIT $ 1,306 M
  • EBITDA $ 1,436 M
  • 60-Month Beta 1.62
  • Price/Sales 14.37
  • Price/Cash Flow 56.44
  • Price/Book 35.88

Options Overview Details

View History
  • Implied Volatility 26.95% ( -0.34%)
  • Historical Volatility 42.86%
  • IV Percentile 38%
  • IV Rank 18.42%
  • IV High 52.99% on 04/08/25
  • IV Low 21.07% on 08/12/25
  • Put/Call Vol Ratio 4.61
  • Today's Volume 320
  • Volume Avg (30-Day) 315
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 6,686
  • Open Int (30-Day) 5,332

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.93
  • Number of Estimates 7
  • High Estimate 3.00
  • Low Estimate 2.87
  • Prior Year 2.62
  • Growth Rate Est. (year over year) +11.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
622.08 +10.91%
on 10/29/25
735.00 -6.13%
on 11/03/25
+53.02 (+8.32%)
since 10/14/25
3-Month
600.57 +14.88%
on 10/01/25
735.00 -6.13%
on 11/03/25
+35.98 (+5.50%)
since 08/14/25
52-Week
356.14 +93.72%
on 04/09/25
735.00 -6.13%
on 11/03/25
+266.28 (+62.85%)
since 11/14/24

Most Recent Stories

More News
Stock Index Futures Plunge on Valuation Concerns

December S&P 500 E-Mini futures (ESZ25) are down -1.01%, and December Nasdaq 100 E-Mini futures (NQZ25) are down -1.31% this morning as quarterly results from AI bellwether Palantir failed to impress investors...

NVDA : 190.17 (+1.77%)
ANET : 131.37 (+0.82%)
SPOT : 635.75 (-1.48%)
SRPT : 18.81 (+5.56%)
GEBN.Z.EB : 628.800 (-1.38%)
MU : 246.83 (+4.17%)
FN : 413.32 (+2.70%)
NQZ25 : 25,152.75 (+0.23%)
AMGN : 336.74 (+0.22%)
PFE : 25.06 (-2.83%)
EDEN.P.DX : 19.298 (-1.79%)
SHOP : 146.04 (-0.21%)
Idexx: Q3 Earnings Snapshot

Idexx: Q3 Earnings Snapshot

IDXX : 689.93 (-1.65%)
IDEXX Laboratories Announces Third Quarter Results

Achieves third quarter revenue growth of 13% as reported and 12% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic. ...

IDXX : 689.93 (-1.65%)
What to Expect From IDEXX Laboratories’ Q3 2025 Earnings Report

IDEXX Laboratories is set to announce its third-quarter results next month, with analysts forecasting robust double-digit growth in earnings.

XLV : 151.83 (-0.60%)
$SPX : 6,734.11 (-0.05%)
IDXX : 689.93 (-1.65%)
IDEXX Laboratories to Release 2025 Third Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Monday, November 3, 2025, before...

IDXX : 689.93 (-1.65%)
IDEXX Laboratories Appoints Karen Peacock to Board

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Idexx Laboratories...

IDXX : 689.93 (-1.65%)
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Cencora (COR) and Amgen (AMGN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Idexx Laboratories (IDXX – Research Report), Cencora (COR – Research Report) and Amgen (AMGN – Research...

COR : 361.94 (-0.80%)
IDXX : 689.93 (-1.65%)
AMGN : 336.74 (+0.22%)
IDEXX Laboratories Elects Karen Peacock to Board of Directors

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Directors, effective October 6, 2025. ...

IDXX : 689.93 (-1.65%)
Stocks Trim Losses as Drug Makers Rally

The S&P 500 Index ($SPX ) (SPY ) today is down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.02%. December E-mini S&P futures...

MSTR : 199.75 (-4.22%)
AMAT : 226.01 (+1.25%)
CTVA : 66.00 (-0.30%)
STE : 258.41 (-0.78%)
MRK : 92.92 (-0.01%)
GLXY : 26.34 (-3.30%)
$IUXX : 25,008.24 (+0.06%)
AMGN : 336.74 (+0.22%)
PFE : 25.06 (-2.83%)
COIN : 284.00 (+0.30%)
ASML : 1,006.98 (-1.26%)
ZNZ25 : 112-170 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 707.84
2nd Resistance Point 703.75
1st Resistance Point 696.84
Last Price 689.93
1st Support Level 685.84
2nd Support Level 681.75
3rd Support Level 674.84

See More

52-Week High 735.00
Last Price 689.93
Fibonacci 61.8% 590.28
Fibonacci 50% 545.57
Fibonacci 38.2% 500.86
52-Week Low 356.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar